RAYMOND JAMES & ASSOCIATES - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$41,700
+19.5%
10,0000.0%0.00%
Q2 2023$34,900
-9.4%
10,0000.0%0.00%
Q1 2023$38,50010,0000.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 449,438$1,928,0002.57%
Opaleye Management Inc. 2,385,000$10,232,0002.17%
AWM Investment Company, Inc. 500,000$2,145,0000.22%
GSA CAPITAL PARTNERS LLP 39,817$171,0000.02%
PARADIGM CAPITAL MANAGEMENT INC/NY 90,000$386,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 203,263$872,0000.02%
CHICAGO TRUST Co NA 16,700$72,0000.01%
Financial Advisors Network, Inc. 10,633$46,0000.01%
Westside Investment Management, Inc. 118,525$3,026,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 28,561$123,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders